Home/Pipeline/ADC Platform

ADC Platform

Platform for Antibody-Drug Conjugate optimization

PlatformActive

Key Facts

Indication
Platform for Antibody-Drug Conjugate optimization
Phase
Platform
Status
Active
Companies

About Differentia Biotech

Differentia Biotech is an AI-driven drug development company building a proprietary digital twin engine to model and simulate the entire drug development pipeline. Its platform combines AI with mechanistic models in clinical pharmacology, pharmacometrics, and systems biology to de-risk development, optimize trial design, and predict human efficacious doses. The company operates as a service and platform provider, offering tailored modeling support to pharmaceutical partners, with a focus on complex modalities like ADCs, cell & gene therapies, and bispecifics. Differentia aims to reduce clinical failures and accelerate the delivery of new therapies by moving critical development questions into the computational realm.

View full company profile

About PrecisemAb Biotech

A Taiwan biotech delivering safer, tumor‑selective antibodies via a protease‑activated lock technology.

View full company profile

Therapeutic Areas